Product & Service News

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--The FIDO Alliance announced today the launch of a new digital credentials initiative, marking an expansion of its mission to accelerate the adoption of verifiable digital credentials and identity wallets. This initiative is poised to help the world simplify and secure online and in-person interactions by establishing a trusted, and interoperable identity wallet ecosystem. Work on this new initiative will be carried out by the FIDO Alliance’s new Digital C...

PRINCETON, N.J.--(BUSINESS WIRE)--BMS's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)...

PERTH, Australia--(BUSINESS WIRE)--Australia’s first Cat® 793 XE Early Learner battery-electric haul trucks have arrived at BHP’s Jimblebar iron ore mine in the Pilbara, marking the start of on-site testing, in collaboration with Rio Tinto, of Caterpillar’s battery-electric heavy haulage technology in the region that powers the nation’s economy. The two Early Learner trucks, delivered through an industry-first collaboration between BHP, Rio Tinto and Caterpillar represent a major step toward a...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance of an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific antibody-drug conjugate (ADC). IDEAYA expects to begin patient enrollm...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance of an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific antibody-drug conjugate (ADC). IDEAYA expects to begin patient enrollm...

WASHINGTON--(BUSINESS WIRE)--Armaments Research Company (ARC), a leader in AI-enabled weapon-mounted sensing, announced that it has been named one of four winners of the U.S. Army’s xTech Counterstrike competition—an internationally scoped effort to identify and accelerate next-generation counter-unmanned aircraft system (C-UAS) technologies. ARC won the “passive sensing” category, enabling soldiers to cue UAS defeat assets at the tactical edge without additional cognitive burden on the soldier...

IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader in neurodiagnostic technology, will showcase its integrated EEG portfolio at the American Epilepsy Society (AES) 2025 Annual Meeting, held December 5–9 in Atlanta. Attendees are invited to Booth #725 to explore solutions shaped through extensive collaboration with the clinicians who use them—bringing together mobility, connectivity and performance to advance neurological care. With a history of advancing EEG technology that predates...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year...

WASHINGTON--(BUSINESS WIRE)--The Public Access to Sunscreens (PASS) Coalition commends Congress for passing the SAFE Sunscreen Standards Act (H.R. 3686/S. 2491) as part of the recent reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA) in H.R. 5371. This action represents a pivotal step toward modernizing sunscreen ingredient approvals and expanding access to safe and innovative cancer prevention tools. For years, outdated regulatory frameworks have restricted Americans’ acces...

PITTSBURGH--(BUSINESS WIRE)--Driven by customer demand and as part of the Company's ordinary course of business planning, U. S. Steel has begun the process to restart the operation of one of two blast furnaces (“B”) at Granite City Works. “After several months of carefully analyzing customer demand, we made the decision to restart a blast furnace,” said David B. Burritt, President and CEO of U. S. Steel. “Steel remains a highly competitive and highly cyclical industry, but we are confident in o...